Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

50.65

+3.27 (6.89%)

Feb 18, 2026, 2:23 PM EST - Market open

Veradermics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-53.81	-26.49	-16.49
Stock-Based Compensation	0.56	0.25	0.21
Other Operating Activities	2.5	1.82	1.85
Change in Accounts Payable	0.78	0.65	1.35
Change in Other Net Operating Assets	-1.22	0.09	-0.43
Operating Cash Flow	-51.61	-23.69	-13.51
Long-Term Debt Issued	-	8.51	-
Long-Term Debt Repaid	-	-0.85	-
Net Debt Issued (Repaid)	-2.51	7.66	-
Other Financing Activities	-0.29	-0.28	-0.04
Financing Cash Flow	59.94	60.48	13.9
Net Cash Flow	-0.75	36.79	0.39
Cash Interest Paid	0.1	0.1	-
Levered Free Cash Flow	-	-16.37	-
Unlevered Free Cash Flow	-	-16.01	-
Change in Working Capital	-0.44	0.73	0.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q